ERBB2 and breast carcinoma: Considering that the numbers of CD163+ TAMs were similar in HER2+ and HER2− tumors, the pro-tumoral functions of CD163+ TAMs can be hypothesized to be especially crucial for the progression of HER2+ breast cancer.